Nintib 150 mg is a prescription medication manufactured by Cipla Ltd. It contains Nintedanib 150 mg as its active ingredient and is primarily used to treat idiopathic pulmonary fibrosis (IPF) and other chronic fibrosing interstitial lung diseases with a progressive phenotype.
Category | anti-fibrotic medicines |
Brand | HETERO |
Ingredient | Nintedanib |
Prescription Required | Yes |
Strength | 150 mg |
Package | 30 Tablets |
Ninlib 150 mg (also known as Nintib 150 mg) contains Nintedanib, a type of medication known as a tyrosine kinase inhibitor. It works by targeting and blocking specific enzymes called tyrosine kinases that are involved in the processes of inflammation, fibrosis (scarring), and the formation of new blood vessels (angiogenesis).
Ninlib 150 mg Tablet offers several key benefits, particularly for individuals suffering from progressive lung diseases like idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases, and certain forms of non-small cell lung cancer (NSCLC). One of its primary advantages is its ability to slow the progression of lung scarring, which helps maintain lung function and improve quality of life over time.
The most common side effects of Ninlib 150mg Tablet:
• Diarrhea
• Nausea
• Vomiting
• Loss of appetite
• Abdominal pain
• Weight loss
• Elevated liver enzymes
• Headache
• High blood pressure (hypertension)
• Fatigue or weakness
Other side effects of Ninlib 150mg Tablet:
• Liver problems (e.g., yellowing of the skin or eyes, dark urine)
• Bleeding complications (e.g., nosebleeds, bruising, gastrointestinal bleeding)
• Gastrointestinal perforation (a rare but serious condition where a hole forms in the wall of the digestive tract)
• Thrombosis (blood clots that can lead to stroke or heart attack)
• Dehydration (often due to persistent diarrhea or vomiting)
• Elevated blood pressure
• Rash or other skin reactions
• Joint or muscle pain
• Kidney dysfunction
• Shortness of breath or worsening lung symptoms
Ninlib 150 mg Tablet should not be taken by individuals who have a known allergy to Nintedanib or any of the other ingredients in the medication, as it may cause severe allergic reactions. It is also not recommended for pregnant women, as it can harm the developing fetus, and should be avoided during breastfeeding, since it is not known whether the drug passes into breast milk. People with severe liver disease or impaired liver function should avoid Ninlib, as the drug is metabolized in the liver and can worsen liver damage.
Ninlib 150 mg Tablet should be taken exactly as prescribed by your doctor, usually twice a day, approximately 12 hours apart, with food to help reduce gastrointestinal side effects. The tablet should be swallowed whole with a glass of water—do not crush, chew, or open the capsule, as this can affect how the medication is absorbed and increase the risk of side effects.
There are no reviews yet.